A novel causative gene variant, TNFRSF13B p.Gly76Ser, in patients with pulmonary arterial hypertension

Back

ESC Premium Access

A novel causative gene variant, TNFRSF13B p.Gly76Ser, in patients with pulmonary arterial hypertension

Session: Burning News from Pulmonary Vascular Disease

Topic: Pulmonary Hypertension

Speaker: Doctor Y. Shinya (Tokyo, JP)

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Doctor Yoshiki Shinya

Keio University School of Medicine, Tokyo (Japan)

0 follower

6 more presentations in this session

Endothelial cell premature senescence exacerbates pulmonary arterial hypertension through contact-mediated interaction with vascular smooth muscle cells.

Speaker: Doctor R. Ramadhiani (Kobe, JP)

Contribution of peptidyl prolyl isomerase (Pin1) to development of pulmonary hypertension via pulmonary vascular endothelial cell dysfunction

Speaker: Professor S. Sakai (Tsukuba, JP)

Kynurenine-PARP 1 link mediated by microRNA 210 may be dysregulated in pulmonary hypertension

Speaker: Associate Professor Y. Yaylali (Denizli, TR)

Nerve growth factor receptor is involved in maintaining homeostasis of pulmonary arterial hypertension

Speaker: Doctor C. Goten (Kanazawa, JP)

Statins for venous thromboembolism prevention: old dog, new tricks

Speaker: Doctor J. Sousa (Porto, PT)

Access the full session

Burning News from Pulmonary Vascular Disease

Speakers: Doctor Y. Shinya, Doctor R. Ramadhiani, Professor S. Sakai, Associate Professor Y. Yaylali, Doctor C. Goten...

Access

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources